MOREPENLAB — Morepen Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹67.69bn
- IN₹69.24bn
- IN₹18.06bn
Brief: India's Morepen Laboratories Ltd Sept Quarter Consol Net Profit Jumps
Brief: Morepen Laboratories Approves Increase In Authorised Share Capital
Brief: India's Morepen Laboratories March Qtr Consol Net Profit Rises
Brief: Morepen Labs Gets UK Standards Body Certification For Baddi Manufacturing Facility
India's Morepen Laboratories rises on license to make Hydroxychloroquine
Brief: Morepen Laboratories Gets License To Manufacture Hydroxychloroquine At Its Baddi Plant
Brief: India's Morepen Laboratories Dec Qtr Consol Net Profit Rises
Brief: India's Morepen Laboratories Sept Qtr Net Profit Falls
Brief: Morepen Laboratories says adds three new drugs to API portfolio.
Brief: Morepen Laboratories: Share Holder Meeting On Hold After SEBI Order
Brief: India Market Regulator Bans Morepen Lab From Accessing Securities Market For 1 Year
Brief: Morepen Laboratories To Issue Up To 37 Mln Warrants Worth Up To 740 Mln Rupees
Brief: India's Morepen Labs To Consider Fundraising
Brief: India's Morepen Laboratories Dec Qtr Net Profit Rises
Brief: India's Morepen Laboratories Sept-Qtr Profit Falls
Brief: Morepen Laboratories Gets Shareholders' Nod For Re-Appointment Of Sushil Suri As Chairman And MD
Brief: India's Morepen Laboratories June Quarter Net Profit Rises
Brief: Morepen Laboratories Says Twin US FDA Approvals For Bulk Drugs Facilities
Brief: India's Morepen Laboratories March-Qtr Net Profit Falls